Microbiota-derived IPA protects against colitis by regulating intestinal HMGCS2-mediated ketogenesis to facilitate mucosal healing

Nat Commun. 2026 Feb 6;17(1):2437. doi: 10.1038/s41467-026-69341-z.

Abstract

The gut microbiota sustains intestinal homeostasis, yet how microbial metabolites direct epithelial repair remains unclear. Here we identify indole-3-propionic acid (IPA), a tryptophan-derived bacterial metabolite, as a key regulator of mucosal healing. IPA activates PPARα in intestinal epithelial cells, enhancing transcription of the ketogenic enzyme HMGCS2 and boosting β‑hydroxybutyrate (BHB) production. BHB in turn stimulates LGR5⁺ intestinal stem cells, accelerating epithelial regeneration. Using germ-free models and the IPA‑producer Peptostreptococcus russellii, we show that dietary tryptophan and specific commensals sustain luminal IPA levels, which are critical for recovery in colitis. Restoration of IPA or BHB attenuates inflammation and barrier defects, outlining a microbiota‑metabolite‑stem cell axis that could be therapeutically targeted in inflammatory bowel disease and other barrier disorders.

MeSH terms

  • 3-Hydroxybutyric Acid / metabolism
  • Animals
  • Colitis* / metabolism
  • Colitis* / microbiology
  • Colitis* / prevention & control
  • Gastrointestinal Microbiome*
  • Humans
  • Indoles* / metabolism
  • Indoles* / pharmacology
  • Intestinal Mucosa* / drug effects
  • Intestinal Mucosa* / metabolism
  • Intestinal Mucosa* / microbiology
  • Intestinal Mucosa* / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Propionates* / metabolism
  • Propionates* / pharmacology
  • Receptors, G-Protein-Coupled / metabolism
  • Stem Cells / metabolism
  • Tryptophan / metabolism

Substances

  • Indoles
  • indolepropionic acid
  • Propionates
  • 3-Hydroxybutyric Acid
  • Tryptophan
  • Receptors, G-Protein-Coupled